Allergy Therapeutics plc

LSE AGY.L

Allergy Therapeutics plc Debt to Equity Ratio for the year ending June 30, 2024: 8.35

Allergy Therapeutics plc Debt to Equity Ratio is 8.35 for the year ending June 30, 2024, a -52.04% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Allergy Therapeutics plc Debt to Equity Ratio for the year ending June 30, 2023 was 17.42, a 6,148.01% change year over year.
  • Allergy Therapeutics plc Debt to Equity Ratio for the year ending June 30, 2022 was 0.28, a 21.12% change year over year.
  • Allergy Therapeutics plc Debt to Equity Ratio for the year ending June 30, 2021 was 0.23, a -17.25% change year over year.
  • Allergy Therapeutics plc Debt to Equity Ratio for the year ending June 30, 2020 was 0.28, a 328.88% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
SV Wall Street
LSE: AGY.L

Allergy Therapeutics plc

CEO Mr. Manuel Llobet
IPO Date Oct. 11, 2004
Location United Kingdom
Headquarters Dominion Way
Employees 612
Sector Healthcare
Industries
Biotechnology Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Pharmaceuticals Plastics Vaccines
Description

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

StockViz Staff

February 5, 2025

Any question? Send us an email